CONSTELLATION PHARMACEUTICALS INC
DelistedCIK 1434418fmd_15NP799P0BKG6Y3782YV90083JManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Mar 31, 2021, 18 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | – | – |
| Research and development | 28 | 33 | 49 | 66 | 96 |
| Total operating expenses | 34 | 39 | 61 | 86 | 125 |
| Operating income | (34) | (39) | (61) | (86) | (125) |
| Interest expense | 1 | 1 | 0 | 2 | 3 |
| Interest and investment income | 0 | 0 | 2 | 3 | 3 |
| Other non-operating income (expense) | (1) | 4 | 1 | 1 | (1) |
| Income before taxes | – | (35) | (60) | (86) | (126) |
| Income tax expense | – | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | (35) | (60) | (86) | (126) |
| Net income | (35) | (35) | (60) | (86) | (126) |
| Net income to common shareholders | (49) | (54) | (60) | (86) | (126) |